Neurocrine Biosciences to Present at the Morgan Stanley 20th Annual Global Healthcare Conference

SAN DIEGO, Sept. 6, 2022 /PRNewswire/ — Neurocrine Biosciences, Inc. (Nasdaq: NBIX) will present at the Morgan Stanley 20th Annual Global Healthcare Conference at 10:35 a.m. Eastern Time on Tuesday, September 13, 2022 in New York. Kevin Gorman, Chief Executive Officer, and Matt…

Click here to view original post